Affiliation:
1. Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Abstract
One recent promising development in the modification of drug formulations to improve chemotherapy is the use of a liposome-mediated drug delivery system. The efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes were evaluated by injecting liposomal drugs and free drugs into tuberculous mice twice a week for 6 weeks. Liposome-encapsulated drugs at and below therapeutic concentrations were more effective than free drugs against tuberculosis, as evaluated on the basis of CFUs detected, organomegaly, and histopathology. Furthermore, liposomal drugs had marginal hepatotoxicities as determined from the levels of total bilirubin and hepatic enzymes in serum. The elimination of mycobacteria from the liver and spleen was also higher with liposomal drugs than with free drugs. The encapsulation of antitubercular drugs in lung-specific stealth liposomes seems to be a promising therapeutic approach for the chemotherapy of tuberculosis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference21 articles.
1. Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines and tetracyclines;Alving C. R.;Life Sci.,1980
2. Virulence of tubercle bacilli isolated from tuberculous patients;Aoki M.;Japan. Rep. Med. Res. Probl. Jpn. Anti-Tuberc. Assoc.,1968
3. Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis;Brande P. V. D.;Am. J. Respir. Crit. Care Med.,1995
4. Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice;Cynamon M. H.;Antimicrob. Agents Chemother.,1989
5. Drug treatment of tuberculosis-1992;Davidson P. T.;Drugs,1992
Cited by
114 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献